Screening ABL1 kinase domain mutations in patients with de novo Philadelphia chromosome-positive (Ph plus ) acute lymphoblastic leukemia (ALL)

被引：1
|
作者：
Li, He [1 ]
Zhang, Wanhua [1 ]
Yi, Dongni [1 ]
Ye, Yuanxin [2 ]
Xiao, Xueqiu [3 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Hematol, Hematol Res Lab, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu, Peoples R China
[3] Sichuan Univ, West China Sch Med, Chengdu, Peoples R China
来源：
LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 04期
关键词：
CHRONIC MYELOID-LEUKEMIA; BCR-ABL; CLINICAL IMPACT; IMATINIB; RESISTANT; THERAPY;
D O I：
10.1080/10428194.2016.1225205
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1005 / 1007
页数：3
相关论文
共 50 条
  • [11] Treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Ryuzo Ohno
    Current Oncology Reports, 2008, 10
  • [12] Involvement of BCR::ABL1 in laminin adhesion of Philadelphia chromosome-positive acute lymphoblastic leukemia through upregulation of integrin α6
    Takahashi, Kazuya
    Nguyen, Thao Thu Thi
    Watanabe, Atsushi
    Sato, Hiroki
    Saito, Kinuko
    Tamai, Minori
    Harama, Daisuke
    Kasai, Shin
    Akahane, Koshi
    Goi, Kumiko
    Kagami, Keiko
    Abe, Masako
    Komatsu, Chiaki
    Maeda, Yasuhiro
    Sugita, Kanji
    Inukai, Takeshi
    CANCER REPORTS, 2024, 7 (04)
  • [13] Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Leonard, Jessica T.
    Rowley, Joelle S. J.
    Eide, Christopher A.
    Traer, Elie
    Hayes-Lattin, Brandon
    Loriaux, Marc
    Spurgeon, Stephen E.
    Druker, Brian J.
    Tyner, Jeffrey W.
    Chang, Bill H.
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (354)
  • [14] Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis
    Soverini, Simona
    Vitale, Antonella
    Poerio, Angela
    Gnani, Alessandra
    Colarossi, Sabrina
    Iacobucci, Ilaria
    Cimino, Giuseppe
    Elia, Loredana
    Lonetti, Annalisa
    Vignetti, Marco
    Paolini, Stefania
    Meloni, Giovanna
    di Maio, Valeria
    Papayannidis, Cristina
    Amabile, Marilina
    Guarini, Anna
    Baccarani, Michele
    Martinelli, Giovanni
    Foa, Robin
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (04): : 552 - 557
  • [15] Managing Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitors
    Ravandi, Farhad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (02) : 198 - 203
  • [16] In vitro drug resistance to imatinib and mutation of ABL gene in childhood Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
    Kawaguchi, H
    Taketani, T
    Hongo, T
    Park, MJ
    Koh, K
    Ida, K
    Kobayashi, M
    Takita, J
    Taki, T
    Yoshino, H
    Bessho, F
    Hayashi, Y
    LEUKEMIA & LYMPHOMA, 2005, 46 (02) : 273 - 276
  • [17] Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
    Ottmann, Oliver G.
    Wassmann, Barbara
    Pfeifer, Heike
    Giagounidis, Aristoteles
    Stelljes, Matthias
    Duehrsen, Ulrich
    Schmalzing, Marc
    Wunderle, Lydia
    Binckebanck, Anja
    Hoelzer, Dieter
    CANCER, 2007, 109 (10) : 2068 - 2076
  • [18] Ponatinib use in two pediatric patients with relapsed Ph plus ALL with ABL1 kinase domain mutations
    Gruner, Stephanie E.
    Sayeed, Hadi
    Suarez-Ferguson, Lizmery
    Perez, Cintia
    Rouce, Rayne
    Fisher, Kevin E.
    Rau, Rachel E.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2019, 36 (08) : 514 - 519
  • [19] Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
    Pfeifer, Heike
    Wassmann, Barbara
    Pavlova, Anna
    Wunderle, Lydia
    Oldenburg, Johannes
    Binckebanck, Anja
    Lange, Thoralf
    Hochhaus, Andreas
    Wystub, Silvia
    Brueck, Patrick
    Hoelzer, Dieter
    Ottmann, Oliver G.
    BLOOD, 2007, 110 (02) : 727 - 734
  • [20] Blinatumomab plus ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
    Couturier, Marie-Anne
    Thomas, Xavier
    Raffoux, Emmanuel
    Huguet, Francoise
    Berthon, Celine
    Simand, Celestine
    Gallego-Hernanz, Maria-Pilar
    Hicheri, Yosr
    Berger, Mathilde Hunault
    Saillard, Colombe
    Leguay, Thibaut
    Loiseau, Clemence
    Bene, Marie-Christine
    Chevallier, Patrice
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 620 - 629
12345